Rowan Walrath
@BosBizRowanCovering life sciences at @BosBizJournal. More often found at @rowanwalrath. Fully vaxed, for planning purposes. she/her. [email protected]
Similar User
@KyleAlspach
@BosBizJournal
@leung
@NewEnglandVC
@ADeAngelis_bio
@RLCscienceboss
@JanelleNanos
@Kadzis
@BentheFidler
@jeff_cranmer
@GlobeAndrewRyan
@BobCoughlin
@Adrian_Walker
@MassTLC
@jonchesto
EXCLUSIVE cover story by @BosBizRowan & @BosBizCatherine: Boston is seeing a boom in lab development. But lab buildings are some of the worst producers of greenhouse gasses, which could complicate the city's efforts to rein in building emissions. bizjournals.com/boston/news/20…
Great story from @BosBizCatherine & @BosBizRowan about the climate change implications of all this lab space taking over Boston. Last year, labs in Boston had 3x carbon emissions per square foot as offices, per BBJ analysis: bizjournals.com/boston/news/20…
Hello. Some non-Covid numbers for a change: @BosBizCatherine and I took a deep dive into the greenhouse gas emissions from Boston's lab buildings last year. Highlights in 🧵 bizjournals.com/boston/news/20…
Petri Dish is a day early, and Bob Langer has co-founded yet another startup: bizjournals.com/boston/news/20… @BosBizJournal
Office buildings in Boston cut their emissions by 21% year-over-year in 2020. The big question is whether they will slingshot back to pre-Covid levels — or worse — as more employees return to the office. Great reporting from @BosBizCatherine & @bygregryan bizjournals.com/boston/news/20…
With $50M, Flagship Pioneering Makes Another Big RNA Play: Alltrna by @rowanwalrath and Boston Business Journal #science #mrna #altrna #solutions #pharmaceuticals #biotech #medical #medicine #healthcare #venturecapital #rna #futureishere lnkd.in/evMCvuAZ
Acrivon Therapeutics has raised $100 million to move a drug licensed from @LillyPad through in-human trials. The company made its public launch just about four months ago. bizjournals.com/boston/news/20…
As more venture capital than ever pours into the Massachusetts life sciences industry, some startups are capitalizing on the trend by raising larger rounds up front. These are the largest 10 Series A rounds of the year so far. bizjournals.com/boston/news/20…
NEW THIS A.M.: George Church discusses the science behind GRO Biosciences, which could provide a workaround for problems in protein therapeutics. The startup just hauled in $25M to tackle those problems. bizjournals.com/boston/news/20… via @BosBizJournal @BosBizRowan
The CEO of one of the area's largest and fastest-growing biotechs, @Alnylam is stepping down in 2022 after a 19-year tenure. He will be replaced by Yvonne Greenstreet, who would become one of the few Black woman CEOs in biotech, via @BosBizRowan $ALNY bizj.us/1qckc9
Ahead of @bostonsci Q3 earnings later this week, analysts say the medical device company has a "higher level of risk" to Covid-19 than other healthcare companies, reports @BosBizRowan $BSX bizj.us/1qcipq
United States Trends
- 1. $ASTROS 2.870 posts
- 2. Taina 2.970 posts
- 3. #SnoopDoggXboxChainGiveaway N/A
- 4. Luka 43,8 B posts
- 5. Greece 47,5 B posts
- 6. Mitch 65,4 B posts
- 7. WNBA 34,3 B posts
- 8. Jamie Foxx 23,3 B posts
- 9. Mel Gibson 20,8 B posts
- 10. Mavs 20,5 B posts
- 11. The Onion 9.745 posts
- 12. Infowars 19,9 B posts
- 13. Randy Moss 4.285 posts
- 14. SantaMoney 3.064 posts
- 15. Jake Burger 2.208 posts
- 16. Shai 16,2 B posts
- 17. Kyrie 12,8 B posts
- 18. #SkeletonCrew 7.448 posts
- 19. Brett 39,8 B posts
- 20. USPS 14,5 B posts
Who to follow
-
Kyle Alspach
@KyleAlspach -
Boston Business Journal
@BosBizJournal -
Shirley Leung
@leung -
The New England Venture Capital Association
@NewEnglandVC -
Allison DeAngelis
@ADeAngelis_bio -
Ryan Cross the Science Boss
@RLCscienceboss -
JanelleNanos
@JanelleNanos -
Peter Kadzis
@Kadzis -
Ben Fidler
@BentheFidler -
Jeff Cranmer
@jeff_cranmer -
Andrew Ryan
@GlobeAndrewRyan -
Bob Coughlin
@BobCoughlin -
Adrian Walker
@Adrian_Walker -
Mass Technology Leadership Council
@MassTLC -
Jon Chesto
@jonchesto
Something went wrong.
Something went wrong.